Holen Sie sich die Stockscreener-App
4.58
4.58%
-0.22
Handel nachbörslich:
4.99
0.41
+8.95%
Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten
Shattuck Labs to present Phase 1 SL-325 data on June 8 - scanx.trade
Shattuck Labs to present phase 1 data for SL-325 on Monday - Investing.com UK
Shattuck Labs to present phase 1 data for SL-325 on Monday By Investing.com - Investing.com South Africa
STTK Upgraded by Citigroup -- Rating Raised to Buy - GuruFocus
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8 - The Manila Times
Shattuck Labs to Present Phase 1 Clinical Data for SL-325 and Pipeline Update on June 8, 2026 - Quiver Quantitative
Shattuck Labs' High-Stakes Bet on a New Era for Autoimmune Treatment - BriefGlance
Shattuck Labs (STTK) Receives Upgrade and Catalyst Watch from Ci - GuruFocus
Citigroup Upgrades Shattuck Labs to Buy From Neutral, Price Target is $7 - marketscreener.com
Citigroup Upgrades Shattuck Labs to Buy From Neutral, Price Target Is $7 - Moomoo
Shattuck Labs (STTK) Receives Upgrade and Catalyst Watch from Citi - GuruFocus
Shattuck Labs, Inc. Amends and Restates 2020 Equity Incentive Plan – SEC 8-K Filing Details - Minichart
Shattuck Labs (STTK) director gets 81,000 stock options at $5.95 - Stock Titan
Shattuck Labs (STTK) director Neil Gibson receives 81,000 stock options at $5.95 - Stock Titan
Shattuck Labs (STTK) investors approve equity plan boost and annual say-on-pay - Stock Titan
Shattuck Labs (STTK) Slips 1.49% as Stock Nears Critical Support at $5.67Value Area Low - The Legal Advocate
STTK Q1 2026 Earnings: Narrower Loss Surprises as Biotech Advances PipelineManagement Guidance Update - The Legal Advocate
Director Clay B. Siegall doubles Shattuck Labs (STTK) holdings with warrant exercise - Stock Titan
Shattuck Labs (STTK) Holds Near Support as Biotech Sentiment ShiftsBearish Sentiment - The Legal Advocate
Shattuck Labs (STTK) Holds Steady at $6.1, Testing Familiar Support LevelsOBV Breakout - Newser
STTK Q1 2026 Earnings: Shattuck Labs Reports Narrower Loss, Beats EPS EstimatesEarnings Yield Analysis - The Legal Advocate
STTK Q1 2026 Earnings: Narrower Loss Surprises, No Revenue as Pipeline Progress ContinuesROIC Trend Report - newsline.com
STTK Q1 2026 Earnings: Narrower-than-expected loss highlights cost discipline amid pre-revenue stageAnnual Report - Newser
Number of shareholders of Shattuck Labs, Inc. – NASDAQ:STTK - TradingView
STTK Insider Buying: CTO Shukla Acquires 5,122 Shares on May 22, 2026 - Meyka
Shattuck Labs (NASDAQ: STTK) CTO exercises 5,122 warrants and increases share holdings - Stock Titan
Shattuck Labs: Priced As If Risk Was Not A Part Of The Equation (NASDAQ:STTK) - Seeking Alpha
Here's Why We're Not Too Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation - Sahm
Officer at Shattuck Labs (NASDAQ: STTK) exercises warrants for 12,805 shares - Stock Titan
Shattuck Labs (STTK) Stock Analysis: -6.15% Loss — Key Levels 2026-05-15Social Trading Insights - newser.com
Shattuck Labs (STTK) Declines -6.15% Amid Market Weakness 2026-05-15Trading Community - newser.com
Shattuck Labs (STTK) Delivers Q1 2026 Beat — EPS $-0.13 vs $-0.14 ExpectedSpecial Dividend - newser.com
T. Rowe Price holds 9.87M shares of Shattuck Labs (NASDAQ: STTK) amendment - Stock Titan
Shattuck Labs CMO Pandite sells $198,300 in stock By Investing.com - Investing.com Nigeria
Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK) - GuruFocus
Shattuck Labs CTO Abhinav Shukla sells $14,244 in shares - Investing.com UK
Shattuck Labs CMO Pandite sells $198,300 in stock - Investing.com
Shattuck Labs CTO Abhinav Shukla sells $14,244 in shares By Investing.com - Investing.com Australia
[Form 4] Shattuck Labs, Inc. Insider Trading Activity - Stock Titan
Shattuck Labs (STTK) CMO sells 30K shares under 10b5-1 plan - Stock Titan
Shattuck Labs stock (US8124231002): Down 5.29% in May 2026 amid biotech volatility - AD HOC NEWS
Shattuck Labs (STTK) CEO exercises warrants to acquire 25,610 common shares - Stock Titan
Shattuck Labs (NASDAQ: STTK) executive reports 968-share tax withholding - Stock Titan
[144] Shattuck Labs, Inc. SEC Filing - Stock Titan
We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK), Novavax (NVAX) and Airsculpt Technologies (AIRS) - The Globe and Mail
STTK Maintained by Wedbush -- Price Target Raised to $11.00 - GuruFocus
Shattuck Labs Price Target Raised to $11.00/Share From $8.00 by Wedbush - Moomoo
1.13%
3.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):